ABBV
AbbVie Inc.
Stock
$266.28+1.94 (+0.73%)Close Sep 28, 2026
ABBV's net income for 2025 was $4.226 billion, down 1.2% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 3, 2026
| Net income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $6.31B | +67.7% | −1.7% | −1.9% |
| Net income (TTM) | $6.31B |
|---|---|
| YoY | +67.7% |
| 5-year CAGR | −1.7% |
| 10-year CAGR | −1.9% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $4.2B | −1.2% |
| 2024 | $4.3B | −12.0% |
| 2023 | $4.9B | −58.9% |
| 2022 | $11.8B | +2.5% |
| 2021 | $11.5B | +150.0% |
| 2020 | $4.6B | −41.4% |
| 2019 | $7.9B | +38.6% |
| 2018 | $5.7B | +7.1% |
| 2017 | $5.3B | −10.8% |
| 2016 | $6.0B | +15.7% |
| 2015 | $5.1B | +190.0% |
| 2014 | $1.8B | −57.0% |
| 2013 | $4.1B | −21.7% |
| 2012 | $5.3B | +53.7% |
| 2011 | $3.4B | — |